PRAVASTATIN GENERICHEALTH pravastatin sodium 10 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pravastatin generichealth pravastatin sodium 10 mg tablet blister pack

generic health pty ltd - pravastatin sodium -

Rennie Extra chewable tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rennie extra chewable tablets

bayer plc - calcium carbonate; alginic acid; magnesium carbonate heavy - chewable tablet - 625mg ; 150mg ; 73.5mg

Rennie Sugar Free Tablets Chewable 680mg & 80mg Malta - English - Medicines Authority

rennie sugar free tablets chewable 680mg & 80mg

bayer plc - calcium carbonate; magnesium carbonate, heavy - chewable tablet - calcium carbonate 68 mg; magnesium carbonate, heavy 80 mg - drugs for acid related disorders

Sodium Chloride 0.45 % w/v and Glucose 5.0 % w/v Solution for Infusion BP Ireland - English - HPRA (Health Products Regulatory Authority)

sodium chloride 0.45 % w/v and glucose 5.0 % w/v solution for infusion bp

baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.45/5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

Sodium Chloride 0.9% w/v Intravenous Infusion BP Ireland - English - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9% w/v intravenous infusion bp

baxter holding b.v. - sodium chloride - solution for infusion - 0.9 percent weight/volume - solutions affecting the electrolyte balance; electrolytes

LITHICARB lithium carbonate 250mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lithicarb lithium carbonate 250mg tablet bottle

aspen pharmacare australia pty ltd - lithium carbonate, quantity: 250 mg - tablet, film coated - excipient ingredients: dextrin; lactose monohydrate; macrogol 6000; sodium starch glycollate type a; purified talc; sodium lauryl sulfate; magnesium stearate; hypromellose; maize starch - mania, both as treatment and prophylaxis; manic depressive (bipolar) illness, both as treatment and as prophylaxis; it is less effective in depressive swings. in recurrent endogenous (unipolar) depressive illness, it is highly effective as prophylaxis in a number of cases, and is probably useful as treatment, especially if there is a family history of manic depressive illness and response to lithium. in some cases of schizoaffective illness and so called chronic schizophrenia it is dramatically effective. those in the latter category who do respond have frequently had affective symptoms at some time. it is used in character or personality disorders in young people with clear evidence of cyclothymia. lithium should not be prescribed until it is certain that the manic depressive swings are established and the course of the disease certain. if the patient has two affective swings in one year, perhaps in opposite directions, and associated with a positive family history, it should certainly be seriously considered. with three episodes in two years, there is no doubt it should be given. as a general rule, it should be prescribed, and therapeutic response assessed, satisfactory maintenance dosage determined, side and toxic effects and associated precautions discussed with the patient and relatives, and blood levels monitored, only under specialist supervision except perhaps in isolated areas. a major management problem also is that there are relatively narrow distances between the therapeutic and toxic dosages and blood levels. for these reasons treatment is preferably commenced on an inpatient basis, so that the patient is under appropriate observation.

BAXTER POTASSIUM CHLORIDE 30 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 30 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 20 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 20 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Esomeprazole TAD 20 mg hard gastro-resistant capsules Malta - English - Medicines Authority

esomeprazole tad 20 mg hard gastro-resistant capsules

tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - esomeprazole magnesium, dihydrate - gastro-resistant hard capsule - esomeprazole magnesium dihydrate 20 mg - drugs for acid related disorders

Esomeprazole TAD 40 mg hard gastro-resistant capsules Malta - English - Medicines Authority

esomeprazole tad 40 mg hard gastro-resistant capsules

tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - esomeprazole magnesium, dihydrate - gastro-resistant hard capsule - esomeprazole magnesium dihydrate 40 mg - drugs for acid related disorders